Makoto Takeuchi

Div Of Experimental Chemotherapy, 3-8-31, Koto Ku
Ariake, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Osteocyte-like differentiation of osteosarcoma by inorganic phosphate.

Osteocyte-like differentiation of osteosarcoma by inorganic phosphate.

Journal: Differentiation; research in biological diversity

Published: June 10, 2025

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

Journal: NPJ breast cancer

Published: September 05, 2024

A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.

A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: May 24, 2024

Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.

Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.

Journal: Cancer science

Published: April 22, 2020

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.

Journal: Cancers

Published: November 04, 2019

On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

Journal: Biomicrofluidics

Published: January 23, 2019

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.

Journal: Oncology letters

Published: April 01, 2018

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.

Journal: Oncotarget

Published: August 15, 2016

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

Journal: Gynecologic oncology

Published: February 02, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026